Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Metformin in Prostate Cancer
NCT00881725Phase 2Terminated
- Sponsor
- University Health Network
- Start
- Jun 2009
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of metformin in prostate cancer (PCa), sponsored by University Health Network. Primary endpoint: Difference in Ki67 staining. Started Jun 2009; status: terminated.
02
Drugs
metformin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00881725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00881725.